Associate Professor Georgina Long has won the InStyle Women In Style Award
14 May 2015
Associate Professor Georgina Long of Melanoma Institute Australia (MIA) has won the InStyle Women In Style Awards for the Science and Environment category. Dr Long was nominated by InStyle over 6 months ago and since then there has been a public voting campaign as well as selection by a very high-powered influential panel of women including Jana Wendt, Collette Dinnigan, Nicola Kidman, Deborah Lee Furness and Layne Beachley.
Other nominees for the Science & Environment category were Kirsty Albion and Lucy Manne (Co-Directors Australian Youth Climate Coalition) and Mara Bún (Founder of Green Cross Australia).
Dr Long is a principal investigator in clinical trials of drugs given to patients with early stage melanoma as well as patients with stage four melanoma at MIA. It is through work like this that a “penicillin moment” is emerging in the field of cancer.
“For the first time we are showing that you can harness the immune system to kill cancer cells,” Dr Long explains.
Dr Long was presented with the award at the InStyle event on Wednesday night.
“I know that life is short, I see that in my work, I want to make the most of every day,” said Dr Long in her acceptance speech.
One person still dies from melanoma every 6 hours in Australia and at MIA we are working hard to change this devastating statistic. With your support we can continue to find melanoma breakthroughs that result in life changing results for melanoma patients.
Help us reach our ultimate goal of finding a cure. Donate now.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.
It was a massive weekend of Melanoma Marches with six Marches in: Bendigo, Canberra, Manly, Newcastle, Bunbury and Adelaide.
Weekend two hit the ground marching with Melanoma Marches in Wollongong, Townsville, Mandurah and Western Sydney.
Melanoma Institute Australia's annual fundraising initiative is all systems go!
The reported proliferation of illegal commercial solariums is costing lives and requires urgent government intervention.
15-year-old melanoma survivor Toby Rayner will lead Mount Gambier’s march against melanoma Julie-Ann Sams knows all too well that melanoma doesn’t discriminate.
Updated guidelines defining appropriate excision margins have been published thanks to research from MIA.
Joanne and her trusty companion Frankie spend their days spreading a message of hope in hospitals, nursing homes, even prisons. It is a long way from her darkest hour facing palliative care. This is her story of hope.
Melanoma impacts more Australian teenagers and young adults than any other cancer. Dr James Wilmott, who has a young family of his own, has devoted his career to determining why these young Australians are susceptible to melanoma, and importantly, how to save them.
Melanoma Masterclass celebrates Australian luminaries who have transformed melanoma treatment worldwide
The extraordinary contribution of Australia’s most distinguished melanoma clinicians and researchers is being celebrated today.
Congratulations to Professor Richard Scolyer who was awarded the William O. Russell/Joanne Vandenberge Hill Award of Excellence in Pathology.
A Day in the Life Of... Serigne Lo, Research and BioStatistics Manager at Melanoma Institute Australia
Jay was your typical Aussie bloke – a truck driver, husband, dad and mate to many. Then he got melanoma. His cancer diagnosis turned his life upside down.
Clair faced an impossible choice – risk delivering her baby early, or delay potentially life-saving melanoma treatment